Business Context and Reporting Period
This Form 8-K filing by BIO-RAD LABORATORIES, INC. was submitted on January 3, 2019, reporting an event that occurred on January 2, 2019. The filing addresses a significant change in executive leadership.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Executive Departure: Christine A. Tsingos, Executive Vice President and Chief Financial Officer, notified the company of her intention to retire.
- Effective Date: Her retirement is effective April 30, 2019.
- Transition Plan: Ms. Tsingos will remain in her current role until the effective date to assist in an orderly transition to a successor.
- Succession: The company has initiated a comprehensive search for a new CFO.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or management commentary regarding future performance. The primary risk disclosed is the operational impact of the CFO departure, which the company is mitigating through a transition period and a search for a successor.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Chief Financial Officer.
- Review the attached press release (Exhibit 99.1) for additional details on the retirement terms.
- Monitor upcoming quarterly earnings calls for updates on the transition progress and any potential impact on financial reporting.